Greenleaf Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $323K | Sell |
|
|||||
|
2025
Q2 | $295K | Buy |
|
|||||
|
2025
Q1 | $289K | Buy |
|
|||||
|
2024
Q4 | $251K | Sell |
|
|||||
|
2024
Q3 | $338K | Sell |
|
|||||
|
2024
Q2 | $396K | Buy |
|
|||||
|
2024
Q1 | $353K | Sell |
|
|||||
|
2023
Q4 | $384K | Sell |
|
|||||
|
2023
Q3 | $550K | Buy |
|
|||||
|
2023
Q2 | $461K | Buy |
|
|||||
|
2023
Q1 | $419K | Buy |
|
|||||
|
2022
Q4 | $391K | Buy |
|
|||||
|
2022
Q3 | $278K | Buy |
|
|||||
|
2022
Q2 | $294K | Sell |
|
|||||
|
2022
Q1 | $349K | Sell |
|
|||||
|
2021
Q4 | $420K | Buy |
|
|||||
|
2021
Q3 | $253K | Sell |
|
|||||
|
2021
Q2 | $347K | Buy |
|
|||||
|
2021
Q1 | $265K | Sell |
|
|||||
|
2020
Q4 | $318K | Sell |
|
|||||
|
2020
Q3 | $447K | Sell |
|
|||||
|
2020
Q2 | $549K | Sell |
|
|||||
|
2020
Q1 | $611K | Buy |
|
|||||
|
2019
Q4 | $747K | Buy |
|
|||||
|
2019
Q3 | $665K | Buy |
|
|||||
|
2019
Q2 | $577K | Sell |
|
|||||
|
2019
Q1 | $652K | Sell |
|
|||||
|
2018
Q4 | $629K | Sell |
|
|||||
|
2018
Q3 | $769K | Sell |
|
|||||
|
2018
Q2 | $774K | Buy |
|
|||||
|
2018
Q1 | $513K | Buy |
|
|||||
|
2017
Q4 | $394K | Buy |
|
|||||
|
2017
Q3 | $58K | Sell |
|
|||||
|
2017
Q2 | $484K | Buy |
|
|||||
|
2017
Q1 | $466K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.19M | Buy |
|
|||||
|
2014
Q4 | $980K | Buy |
|
|||||
|
2014
Q3 | $872K | Buy |
|
|||||
|
2014
Q2 | $775K | Buy |
|
|||||
|
2014
Q1 | $716K | Sell |
|
|||||
|
2013
Q4 | $785K | Sell |
|
|||||
|
2013
Q3 | $748K | Sell |
|
|||||
|
2013
Q2 | $807K | Buy |
|